Zhinuan Yu

Corporate VP, Biometrics & Regulatory Enabling Functions at Antengene

Dr. Yu has over 20 years of experience in the pharmaceutical industry and led the statistical support at Celgene for multiple high-priority programs, including thalidomide, lenalidomide, pomalidomide, and bb2121 (CAR-T).

Location

Martinsville, United States

Links


Org chart


Teams


Offices

This person is not in any offices


Antengene

Driven by its vision of “Treating Patients Beyond Borders”, Antengene aims to provide the most advanced anti-cancer drugs to patients in the Asia Pacific Region and around the world.


Industries

Headquarters

Shanghai, China

Employees

51-200

Links